Masterclasses in Dermatology
J

Comorbidities of Psoriasis and PsA

By Masterclasses in Dermatology FEATURING Jeffrey Cohen
By Masterclasses in Dermatology FEATURING Jeffrey Cohen
0 views
November 29, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi

Featured Video

26:13
Lilly Diabetes

A Journey through Five Phase 3 Clinical Trials for a T2D Incretin Me…

Feat. B. Hirsch

Recommended

AUTOPLAY
15:37
Houston Methodist Hospital

Traumatic Brain Injury

Feat. M. E. Zwillman
22:08
RheumNow

RheumNow News Highlights: 11 Agents That Cause Arthritis, Lupus - Te…

Feat. J. Cush
18:57
Masterclasses in Dermatology

Safety and Monitoring Considerations in Systematic Therapy

Feat. J. Cohen
25:57
Masterclasses in Dermatology

Imaging Considerations for the Dermatologist

Feat. C. Bakewell
17:42
Brigham and Women's Hospital Department of Dermatology

AAD 2024 Insights: Prevention and Active Surveillance of Keratinocyt…

Feat. R. Hartman
17:41
Stephan Herzig

EASD Insights: Long-term Complications in Diabetes - From Classical …

28:32
West Virginia State Rheumatology Society

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

Feat. J. Bustamante
11:53
AAD 2024 Insights

AAD 2024 Insights: Immunomodulators in Non-Melanoma Skin Cancer

Feat. V. Patel
27:14
2024 Clinical Case Studies

Clinical Case Review: Cutaneous T Cell Lymphoma in the Patch Test Cl…

Feat. J. Murase
13:16
ASH 2022 Conference Coverage

Experts Discuss Key Updates in CLL

Feat. S. O'Brien, C. Coombs
10:18
RheumNow

Points to Consider When Managing Inflammatory Arthritis with Cancer

Feat. J. Cush
10:12
USSONAR

USSONAR Rheumatology Ultrasound Case Series: A Case of Dactylitis in…

Feat. J. Medlin
11:16
Amaris Geisler

We Never Looked: What Happens When Gynecologic Care Ceases After Age…

10:35
Alan Skarbnik

Learnings From the ELEVATE-TN Phase 3 Trial: Acalabrutinib+/-Obinutu…

15:11
Nour Kibbi

Diagnosis and Management of Rare Skin Cancers: What Every Dermatolog…

04:14
ecancer

ALPINE: A Randomized Phase 3 Study of Zanubrutinib vs. Ibrutinib for…

Feat. J. Brown
18:04
Seema Bhat

Zanubrutinib for the Treatment of CLL: Learnings From ALPINE, SEQUOI…

06:53
Fred Hutchinson Cancer Center

Surveying Safety and Efficacy Data in R/R CLL: ALPINE and ELEVATE-RR…

Feat. M. Shadman
13:22
International Psoriasis Council (IPC)

Challenging Case: A Patient with Comorbid Solid Organ Malignancy

Feat. M. Angeliki Gkini
10:02
2023 Year in Review

Year in Review: Xeroderma Pigmentosum

Feat. A. Chacon